CXCL2 and pulmonary fibrosis: CXCL2 is significantly upregulated in mouse lung tissue in a bleomycin-induced model of pulmonary fibrosis, and 5-azacytidine (a DNA methyltransferase inhibitor) reduces CXCL2 expression (23).